Manitoba Population Research Data Repository: Burns Registry (Canada)

Database Contact Data

Manitoba Centre for Health Policy
Community Health Sciences, Max Rady College of Medicine
Rady Faculty of Health Sciences
Room 408-727 McDermot Ave.
Winnipeg, Manitoba
R3E 3P5
CANADA
Phone: +1(204) 789-3819
Email: info@cpe.umanitoba.ca

Alternate Contact

University of Manitoba
Winnipeg, Manitoba
CANADA
Phone: 1-800-432-1960

References of Studies Using/Describing Database

1. Japandeep Sethi, BSc, Justin P Gawaziuk, MSc, Nora Cristall, MSW, PhD, Sarvesh Logsetty, MD, The Relationship Between Income and Burn Incidence in Winnipeg, Manitoba, Canada: A Population Health Study, Journal of Burn Care & Research, Volume 39, Issue 5, September/October 2018, Pages 645–651.

2. Logsetty S, Shamlou A, Gawaziuk JP, March J, Doupe M, Chateau D, Hoppensack M, Khan S, Medved M, Leslie WD, Enns MW, Stein MB, Asmundson GJ, Sareen J. Mental health outcomes of burn: A longitudinal population-based study of adults hospitalized for burns. Burns. 2016 Jun;42(4):738-44.

3. Stone J, Gawaziuk JP, Khan S, Chateau D, Bolton JM, Sareen J, Enns J, Doupe M, Brownell M, Logsetty S. Outcomes in Adult Survivors of Childhood Burn Injuries as Compared with Matched Controls. J Burn Care Res. 2016 Mar-Apr;37(2):e166-73. 

PatientsMap (Japan)

Database Contact Data

Email: patientsmap@ssri.com

Alternate Contact

Social Survey Research Information (SSRI)
Please complete the contact form at: https://www.ssri.com/e/contact_us

References of Studies Using/Describing Database

Please visit https://research.ssri.co.jp/pmap/pastdata

Maccabi Healthcare Services (MHS): HCV Registry (Israel)

Database Contact Data

Sarit Chehanowitz
Head of Big Data & Business Development
Maccabi Healthcare Services
ISRAEL
Email: chehanow_s@mac.org.il

Alternate Contact

Email: leopold_e@mac.org.il

References of Studies Using/Describing Database

1. Cornberg M, Ahumada A, Aghemo A, Andreoni M, Bhagat A, Butrymowicz I, Carmiel M, Chodick G, Conway B, Song Y, Gasbarrini A, Hüppe D, Plaza FJ, Lampertico P, Alonso MLM, Myles L, Persico M, Ramji A, Sarrazin C, Villa E, Weil C, Otano JIU; CREST Study Group. Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study. Adv Ther. 2022 Jul;39(7):3146-3158. 

2. Weil C, Mehta D, Koren G, Pinsky B, Samp JC, Chodick G, Shalev V. Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real-world data from a large healthcare provider. J Viral Hepat. 2018 Feb;25(2):144-151.

3. Weil C, Nwankwo C, Friedman M, Kenet G, Chodick G, Shalev V. Epidemiology of hepatitis C virus infection in a large Israeli health maintenance organization. J Med Virol. 2016 Jun;88(6):1044-50.

4. Weil C, Nwankwo C, Friedman M, Shalev V, Chodick G. Real-World Data on Multiple Comorbidities Among Patients With Hepatitis C: Considerations for Patient Care And Prognosis. VOLUME 18, ISSUE 7, PA543, NOVEMBER 01, 2015. Value Health/ISPOR - Open Archive DOI:https://doi.org/10.1016/j.jval.2015.09.1723.

NOTE: For more recent publications, please reach out to the database contacts.

Subscribe to